(e) On November 5, 2009, at the Company's 2009 Annual Meeting of Stockholders, the stockholders of the Company approved an amendment to the Company's 2003 Employee, Director and Consultant Stock Option Plan, as previously amended (the "Option Plan"), to increase the number of shares of common stock available for issuance thereunder by 3,000,000 shares. However, as noted in the supplement to our proxy statement as filed with the SEC on October 28, 2009, following the Annual Meeting, the Company's Board of Directors amended the Option Plan to reduce the additional number of shares of common stock to be added by 1,000,000 shares to 2,000,000 shares.

The Option Plan, as amended to increase the number of shares of common stock available for issuance thereunder by 2,000,000 shares, is attached hereto and is being filed pursuant to this Item 5.02 as Exhibit 10.1 to this Current Report on Form 8-K.

(d) The following exhibit is filed with this report:

Exhibit
Number                                    Description

 10.1        Myriad Genetics, Inc. 2003 Employee, Director and Consultant Stock
             Option Plan, as amended.

Page 2 of 4 pages